Gland Pharma Limited (BOM:543245)
1,761.75
-11.55 (-0.65%)
At close: Apr 28, 2026
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 290.10 billion as of April 28, 2026. Its market cap has increased by 19.39% in one year.
Market Cap
290.10B
Enterprise Value
261.11B
Revenue
61.13B
Ranking
n/a
PE Ratio
34.24
Stock Price
1,761.75
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has decreased from 297.10B to 290.10B, a decrease of -2.36%. That is a compound annual growth rate of -0.44%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 321.75B |
| AstraZeneca Pharma India | 212.54B |
| GlaxoSmithKline Pharmaceuticals | 418.95B |
| Granules India | 170.76B |
| Rubicon Research | 154.65B |
| Jubilant Pharmova | 149.60B |
| Abbott India | 535.45B |
| Caplin Point Laboratories | 130.50B |